136 related articles for article (PubMed ID: 1828975)
1. Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.
Laquerriere A; Raguenez-Viotte G; Paraire M; Bizzari JP; Paresy M; Fillastre JP; Hemet J
Eur J Cancer; 1991; 27(5):630-8. PubMed ID: 1828975
[TBL] [Abstract][Full Text] [Related]
2. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
[TBL] [Abstract][Full Text] [Related]
3. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Weiss RB; Issell BF
Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
[No Abstract] [Full Text] [Related]
4. Nitrosoureas in the Management of Malignant Gliomas.
Brandes AA; Bartolotti M; Tosoni A; Franceschi E
Curr Neurol Neurosci Rep; 2016 Feb; 16(2):13. PubMed ID: 26750128
[TBL] [Abstract][Full Text] [Related]
5. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
Sariban E; Erickson LC; Kohn KW
Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
Winter S; Weller M
Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
[TBL] [Abstract][Full Text] [Related]
7. Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex.
Meulemans A; Giroux B; Hannoun P; Henzel D; Bizzari JP; Mohler J
Chemotherapy; 1989; 35(5):313-9. PubMed ID: 2791708
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
Zackheim HS; Smuckler EA
Experientia; 1980 Oct; 36(10):1211-2. PubMed ID: 7418808
[TBL] [Abstract][Full Text] [Related]
9. Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies.
Meulemans A; Giroux B; Hannoun P; Robine D; Henzel D
Chemotherapy; 1991; 37(2):86-92. PubMed ID: 2032474
[TBL] [Abstract][Full Text] [Related]
10. The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. Ultrastructural evidence of a delayed microtubular toxicity.
Ducastelle T; Raguenez-Viotte G; Fouin-Fortunet H; Matysiak M; Hemet J; Fillastre JP
Cancer Chemother Pharmacol; 1988; 22(2):153-62. PubMed ID: 3409447
[TBL] [Abstract][Full Text] [Related]
11. The nitrosoureas: an outline of clinical schedules and toxic effects.
Wasserman TH
Cancer Treat Rep; 1976 Jun; 60(6):709-11. PubMed ID: 954008
[No Abstract] [Full Text] [Related]
12. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
Drewinko B; Loo TL; Gottlieb JA
Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions.
Brakenhoff JP; Commandeur JN; Wormhoudt LW; Groot EJ; Vermeulen NP
Carcinogenesis; 1996 Apr; 17(4):715-24. PubMed ID: 8625482
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.
Guaitani A; Corada M; Lucas C; Lemoine A; Garattini S; Bartosek I
Cancer Chemother Pharmacol; 1991; 28(4):293-7. PubMed ID: 1879046
[TBL] [Abstract][Full Text] [Related]
15. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
Suling WJ; Rice LS; Shannon WM
J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
[TBL] [Abstract][Full Text] [Related]
17. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
Russo RG; Cattaneo MT; Bartosek I
Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
